Skip to Main Content

Hello, everyone, and how are you today? We are coping, thank you, despite the ongoing calamity engulfing all of us these days. We are keeping busy with our usual routine of phone calls, deadlines, and foraging for interesting items. In other words, we remain productively distracted. Hopefully you are as well. Meanwhile, please join us for a cup of stimulation as we get cracking. Hope your day is manageable and, most of all, safe. And please do keep in touch.

The world will need more than one Covid-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, GlaxoSmithKline (GSK) chief executive officer Emma Walmsley tells Reuters. GSK and Sanofi (SNY) plan to develop a vaccine to fight the fast-spreading coronavirus. The drug makers expect to start clinical trials for the vaccine in the second half of this year and, if successful, the vaccine would be available in the second half of 2021.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!